Skip to main content

Immucell Value Stock - Dividend - Research Selection

Immucell

ISIN: US4525253062, WKN: 885825

Market price date: 08.01.2021
Market price: 6,25 USD




Immucell Fundamental data and company key figures of the share

Annual reports in USD
Key figures 29-03-2020
Cash flow
Net operating cash flow 233.511
Capital Expenditures -1.391.450
Free cash flow -1.157.939
Balance sheet
Total Equity 28.991.300
Liabilities & Shareholders equity 38.691.800
Income statement
Net income -1.295.590
Eps (diluted) -0,190
Diluted shares outstanding 6.818.890
Net sales/revenue 13.723.000

Fundamental ratios calculated on: 08-01-2021

Ratios
Key figures 08-01-2021
Cash flow
P/C 0,00
   
P/FC 0,00
Balance sheet
ROI-3,35
ROE74,93
Income statement
P/E-32,90
Div. Yield0,00%
P/B0,00
P/S3,11


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolICCC
Market Capitalization42.618.064,00 USD
CountryUnited States
IndicesNASDAQ Comp.
SectorsPharma
Raw Data SourceUS GAAP in Millionen USD
Stock Split1990-07-26,1.0000/100.0000; 1990-07-25,1.0000/100.0000; 1990-07-24,1.000000/100.000000
Internetwww.immucell.com


Description of the company

ImmuCell Corporation, an animal health company, develops, acquires, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company primarily offers First Defense, an orally delivered scours preventive product for newborn calves. It also provides California Mastitis Test, which is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic. In addition, the company is involved in developing purified Nisin treatment for subclinical mastitis in lactating dairy cows; and selling various product applications of its First Defense Technology, including a whey protein concentrate for the nutritional and feed supplement markets. ImmuCell Corporation sells its products to animal health distributors, fleet stores, and direct to farms. The company was founded in 1982 and is headquartered in Portland, Maine.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.immucell.com